.
MergerLinks Header Logo

New Deal

New Deal

Announced

Al Hammadi Company for Development and Investment to acquire a 35% stake in Sudair Pharmaceuticals from Gulf Investment for $32m.

Synopsis

Al Hammadi Company for Development and Investment, a hospitals and medical centers operator, agreed to acquire a 35% stake in Sudair Pharmaceuticals, a pharmaceutical company, from Gulf Investment, an investment company, for $32m.

Principals

Sudair Pharmaceuticals

target

Sudair Pharmaceuticals

Al Hammadi Company For Development And Investment

bidder

Al Hammadi Company For Development And Investment

Show Details & Financials

Market Context

Yasser Alobaida

Yasser Alobaida

Founder and CEO at SUDAIR PHARMACEUTICALS
Deal Bio
Total Deals
1/
Total Value
£24M
Mohammad bin Saleh Mohammad Al-Hammadi

Mohammad bin Saleh Mohammad Al-Hammadi

Executive Director and CEO at AL HAMMADI COMPANY FOR DEVELOPMENT AND INVESTMENT
Deal Bio
Total Deals
1/
Total Value
£24M
Simon Rahimzada

Simon Rahimzada

Partner at King & Spalding
Deal Bio
Total Deals
5/
Total Value
£1,072M
Jassim Seddiqi

Jassim Seddiqi

CEO at GULF INVESTMENT CORPORATION
Deal Bio
Total Deals
1/
Total Value
£24M

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required
Register nowSign up with LinkedIn

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US